Point72 Asset Management
CRBU icon

Point72 Asset Management’s Caribou Biosciences CRBU Stock Holding History

Point72 Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,000
Closed -$196K – 2133
2024
Q3 		$196K Buy
+100,000
New +$205K ﹤0.01% 1796

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management's CRBU Position: Q1 2026 in Review

Point72 Asset Management reduced its Caribou Biosciences (CRBU) stake by 54% in Q1 2026, selling an estimated $371K and leaving 187,622 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #3293.

Point72 Asset Management first reported a position in CRBU in Q3 2021 and has held it in 18 quarters since. The position peaked at $20.2M in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Point72 Asset Management held 187,622 shares of Caribou Biosciences worth $356K as of Q1 2026.
  • Point72 Asset Management sold 216,316 Caribou Biosciences shares in Q1 2026, an estimated $371K.
  • Caribou Biosciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3293 holding.
  • Point72 Asset Management first reported a position in Caribou Biosciences in Q3 2021 and has held it in 18 quarters since.
  • Point72 Asset Management's Caribou Biosciences position peaked at $20.2M in Q4 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.